Clinical Trial

Salivary microRNA in Endometriosis: Correlation With Response to Progestin Therapy

Study acronym: ENDOmiRNA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 2, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to analyze the salivary miRNA specific for patients diagnosed with endometriosis, specifically evaluating the miRNA profile of patients who respond versus those who do not respond to progestin therapy. Ninety patients attending the Chronic Pelvic Pain Clinic will be recruited, and they will be asked to provide a saliva sample before starting medical therapy. The response to the therapy will be evaluated after 4 months from the beginning of the therapy itself.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-09.
Trial Details
NCT Number NCT06414720
Lead Sponsor University of Udine
Conditions Endometriosis
Enrollment 90 participants
Start Date 2024-04-22
Primary Completion 2025-12-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-02